SCHEMBL5694032

SCHEMBL5694032

Cc1ccccc1S(=O)(=O)n1cnnn1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
RAPGEF4 Q8WZA2 1/20 0.42
CTSG P08311 1/20 0.39
CMA1 P23946 1/20 0.39
ALDH1A1 P00352 4/20 0.38
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.36
CPB1 P15086 1/20 0.35
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
TP53 P04637 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
HPGD P15428 1/20 0.34
NOTUM Q6P988 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
EDNRA P25101 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10545631 0.81 PKM (0.49) GAAALDH1A1PKMRAB9AKDM4E
SCHEMBL11199689 0.79 KDM4E (0.48) GAAALDH1A1PKMRAB9AKDM4E
SCHEMBL8712666 0.75 NOTUM (0.42) ALDH1A1L3MBTL1TDP1NOTUM
SCHEMBL6582500 0.71 GAA (0.54) GAARAPGEF4CTSGCMA1ALDH1A1
SCHEMBL5694221 0.71 RAPGEF4 (0.45) GAARAPGEF4ALDH1A1RAB9AKDM4E
SCHEMBL11225129 0.71 MAPT (0.60) GAAALDH1A1KDM4EL3MBTL1TDP1
SCHEMBL28402395 0.69 PTGS2 (0.45) GAARAPGEF4CTSGCMA1ALDH1A1
SCHEMBL27461811 0.69 ELANE (0.47) GAARAPGEF4CTSGCMA1ALDH1A1
SCHEMBL6024620 0.67 RAPGEF4 (0.53) RAPGEF4CTSGCMA1ALDH1A1KDM4E
SCHEMBL5369302 0.67 CYP3A4 (0.59) GAACTSGCMA1ALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230123981-A1 4'-O-METHYLENE PHOSPHONATE NUCLEIC ACIDS AND ANALOGUES THEREOF NOVO NORDISK A/S (DK) 2023-04-20 US disclosed
EP-4090665-A1 4'-O-METHYLENE PHOSPHONATE NUCLEIC ACIDS AND ANALOGUES THEREOF Dicerna Pharmaceuticals, Inc. (US) 2022-11-23 EP disclosed
WO-2021146488-A1 4'-O-METHYLENE PHOSPHONATE NUCLEIC ACIDS AND ANALOGUES THEREOF DICERNA PHARMACEUTICALS, INC. (US) 2021-07-22 WO disclosed
US-20060167241-A1 Method for synthesizing cyclic bisdinucleoside MITSUI CHEMICALS, INC. (JP) 2006-07-27 US disclosed
EP-1645561-A1 METHOD OF SYNTHESIZING CYCLIC BISDINUCLEOSIDE Mitsui Chemicals, Inc. (JP) 2006-04-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167241-A1 Method for synthesizing cyclic bisdinucleoside NSUN2, POLR2H, POLB GAA 3189/4885RAPGEF4 3437/4885CTSG 3274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.